Should You Think About Buying Doximity, Inc. (NYSE:DOCS) Now? [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, what if the stock is still a bargain? Let's take a look at Doximity's outlook and value based on the most recent financial data to see if the opportunity still exists. View our latest analysis for Doximity Is Doximity Still Cheap? According to our valuation model, Doximity seems to be fairly priced at around 17% below our intrinsic value, which means if you buy Doximity today, you'd be paying a reasonable price for it. And if you believe the company's true value is $35.82, then there isn't much room for the share price grow beyond what it's currently trading. Although, there may be an opportunity to buy in the future. This is because Doximity's beta (a measure of share price volatility) is high, meani
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity (DOCS) Gains As Market Dips: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical ProceduresBusiness Wire
- DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- Investors Are Encouraged To Join The Schall Law Firm In An Inquiry Into Physicians Realty Trust For Securities FraudAccesswire
- What Makes Doximity (DOCS) a Good Short Position? [Yahoo! Finance]Yahoo! Finance
DOCS
Earnings
- 8/8/24 - Beat
DOCS
Sec Filings
- 9/5/24 - Form 4
- 9/3/24 - Form 144
- 8/30/24 - Form 4
- DOCS's page on the SEC website